You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

DSUVIA Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Dsuvia, and what generic alternatives are available?

Dsuvia is a drug marketed by Vertical Pharms and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has one hundred and five patent family members in twenty countries.

The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dsuvia

A generic version of DSUVIA was approved as sufentanil citrate by HIKMA on December 15^th, 1995.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DSUVIA?
What are the global sales for DSUVIA?
What is Average Wholesale Price for DSUVIA?

Summary for DSUVIA

International Patents:	105
US Patents:	21
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	22
Clinical Trials:	3
Drug Prices:	Drug price information for DSUVIA
What excipients (inactive ingredients) are in DSUVIA?	DSUVIA excipients list
DailyMed Link:	DSUVIA at DailyMed

Drug patent expirations by year for DSUVIA

Drug Prices for DSUVIA

Recent Clinical Trials for DSUVIA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
United States Department of Defense	Phase 3
Frank Guyette	Phase 3
Montefiore Medical Center	Phase 4

See all DSUVIA clinical trials

Pharmacology for DSUVIA

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

US Patents and Regulatory Information for DSUVIA

DSUVIA is protected by twenty-one US patents.

Patents protecting DSUVIA

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for DSUVIA

See the table below for patents covering DSUVIA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	5322949		⤷ Sign Up
Denmark	3072504		⤷ Sign Up
Spain	2785300		⤷ Sign Up
Canada	2848274	DISPOSITIFS DE DISTRIBUTION ET DE STOCKAGE DE MEDICAMENTS ET SYSTEMES COMPRENANT CEUX-CI (DRUG STORAGE AND DISPENSING DEVICES AND SYSTEMS COMPRISING THE SAME)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for DSUVIA

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2114383	300797	Netherlands	⤷ Sign Up	PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922
2114383	16C0010	France	⤷ Sign Up	PRODUCT NAME: SUFENTANIL; REGISTRATION NO/DATE: EU/1/15/1042 20150918
2114383	CR 2016 00007	Denmark	⤷ Sign Up	PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922
2114383	122016000023	Germany	⤷ Sign Up	PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.